Santhera Provides Update on the Ongoing Regulatory Review of Puldysa® (Idebenone) by the CHMP in Duchenne Muscular Dystrophy (DMD)

Print Friendly, PDF & Email

DUCHENNE MD RELATED: A conference call will be held today at 13:00 CEST, 12:00 BST, 07:00 EDT. Details are at the end of this statement. Pratteln, Switzerland, May 29, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces that the EMA’s CHMP has granted a requested extension of the clock-stop in the regulatory procedure […]